Polamarasetty Aparoy

1.2k total citations
35 papers, 947 citations indexed

About

Polamarasetty Aparoy is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Polamarasetty Aparoy has authored 35 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 15 papers in Molecular Biology and 13 papers in Organic Chemistry. Recurrent topics in Polamarasetty Aparoy's work include Inflammatory mediators and NSAID effects (12 papers), Computational Drug Discovery Methods (11 papers) and Synthesis and biological activity (10 papers). Polamarasetty Aparoy is often cited by papers focused on Inflammatory mediators and NSAID effects (12 papers), Computational Drug Discovery Methods (11 papers) and Synthesis and biological activity (10 papers). Polamarasetty Aparoy collaborates with scholars based in India, Germany and United States. Polamarasetty Aparoy's co-authors include Pallu Reddanna, Bhusan K. Kuntal, Neha Chaudhary, M. Rami Reddy, Hartmut Kühn, Dagmar Heydeck, T. Chandramohan Reddy, R.S. Rathore, Thomas Horn and Mark D. Erion and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Computational Chemistry.

In The Last Decade

Polamarasetty Aparoy

32 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Polamarasetty Aparoy India 16 470 257 240 215 70 35 947
Theodora M. Steindl Austria 14 491 1.0× 272 1.1× 376 1.6× 154 0.7× 32 0.5× 17 878
Zongru Guo China 19 493 1.0× 545 2.1× 224 0.9× 248 1.2× 51 0.7× 53 1.3k
Florian Kaiser Germany 12 788 1.7× 323 1.3× 251 1.0× 154 0.7× 45 0.6× 24 1.5k
Katrin Stierand Germany 10 677 1.4× 230 0.9× 304 1.3× 134 0.6× 25 0.4× 15 1.2k
Vivek K. Vyas India 20 726 1.5× 335 1.3× 352 1.5× 182 0.8× 32 0.5× 86 1.4k
Jonathan M. Schmidt Canada 10 570 1.2× 363 1.4× 370 1.5× 310 1.4× 26 0.4× 19 1.1k
Song Wu China 22 705 1.5× 341 1.3× 244 1.0× 274 1.3× 28 0.4× 114 1.5k
Vânia M. Moreira Portugal 19 716 1.5× 258 1.0× 212 0.9× 80 0.4× 22 0.3× 53 1.2k
Zhenquan Hu China 16 648 1.4× 256 1.0× 224 0.9× 161 0.7× 23 0.3× 33 1.3k
Marco A. C. Neves Portugal 12 639 1.4× 217 0.8× 264 1.1× 130 0.6× 19 0.3× 16 1.1k

Countries citing papers authored by Polamarasetty Aparoy

Since Specialization
Citations

This map shows the geographic impact of Polamarasetty Aparoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Polamarasetty Aparoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Polamarasetty Aparoy more than expected).

Fields of papers citing papers by Polamarasetty Aparoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Polamarasetty Aparoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Polamarasetty Aparoy. The network helps show where Polamarasetty Aparoy may publish in the future.

Co-authorship network of co-authors of Polamarasetty Aparoy

This figure shows the co-authorship network connecting the top 25 collaborators of Polamarasetty Aparoy. A scholar is included among the top collaborators of Polamarasetty Aparoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Polamarasetty Aparoy. Polamarasetty Aparoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parvez, Suhel, et al.. (2025). Molecular dynamics simulations to decipher the hotspots at the allosteric site of human 5-lipoxygenase. Journal of Molecular Graphics and Modelling. 136. 108940–108940.
2.
Kumar, Manoj, Polamarasetty Aparoy, Saroj Kumar, et al.. (2025). In Silico Screening and Molecular Dynamics Simulations of Small Molecules Targeting Peptidyl tRNA Hydrolase for Drug-Resistant Tuberculosis. ACS Omega. 10(33). 37115–37127.
3.
Rothe, Michael, et al.. (2023). Bony Fish Arachidonic Acid 15-Lipoxygenases Exhibit Different Catalytic Properties than Their Mammalian Orthologs, Suggesting Functional Enzyme Evolution during Vertebrate Development. International Journal of Molecular Sciences. 24(18). 14154–14154. 2 indexed citations
4.
Ivanov, Igor, Elena V. Shmendel, Michael Rothe, et al.. (2021). Oxygenation of endocannabinoids by mammalian lipoxygenase isoforms. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1866(6). 158918–158918. 5 indexed citations
5.
6.
Aparoy, Polamarasetty, et al.. (2018). Role of Topological, Electronic, Geometrical, Constitutional and Quantum Chemical Based Descriptors in QSAR: mPGES-1 as a Case Study. Current Topics in Medicinal Chemistry. 18(13). 1075–1090. 8 indexed citations
7.
Aparoy, Polamarasetty, et al.. (2016). Insights into the structure activity relationship of mPGES-1 inhibitors: Hints for better inhibitor design. International Journal of Biological Macromolecules. 88. 624–632. 8 indexed citations
8.
Chaudhary, Neha, et al.. (2015). The Augmenting Effects of Desolvation and Conformational Energy Terms on the Predictions of Docking Programs against mPGES-1. PLoS ONE. 10(8). e0134472–e0134472. 17 indexed citations
9.
10.
Horn, Thomas, Ralf R. Schumann, Saubashya Sur, et al.. (2014). Evolutionary aspects of lipoxygenases and genetic diversity of human leukotriene signaling. Progress in Lipid Research. 57. 13–39. 76 indexed citations
11.
Filosa, Rosanna, Antonella Peduto, Polamarasetty Aparoy, et al.. (2013). Discovery and biological evaluation of novel 1,4-benzoquinone and related resorcinol derivatives that inhibit 5-lipoxygenase. European Journal of Medicinal Chemistry. 67. 269–279. 37 indexed citations
12.
Aparoy, Polamarasetty, et al.. (2012). Structure and Ligand Based Drug Design Strategies in the Development of Novel 5- LOX Inhibitors. Current Medicinal Chemistry. 19(22). 3763–3778. 133 indexed citations
13.
Reddy, T. Chandramohan, et al.. (2011). Structure based drug design, synthesis and evaluation of 4-(benzyloxy)-1-phenylbut-2-yn-1-ol derivatives as 5-lipoxygenase inhibitors. European Journal of Medicinal Chemistry. 47(1). 351–359. 14 indexed citations
14.
Aparoy, Polamarasetty, et al.. (2010). Design, synthesis, and biological evaluation of prenylated chalcones as 5-LOX inhibitors. Bioorganic & Medicinal Chemistry. 18(16). 5807–5815. 36 indexed citations
15.
Kuntal, Bhusan K., Polamarasetty Aparoy, & Pallu Reddanna. (2010). Development of Tools and Database for Analysis of Metal Binding Sites in Protein. Protein and Peptide Letters. 17(6). 765–773. 9 indexed citations
16.
Gullipalli, Damodar, Abul Arif, Polamarasetty Aparoy, et al.. (2010). Identification of a developmentally and hormonally regulated Delta-Class glutathione S-transferase in rice moth Corcyra cephalonica. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 156(1). 33–39. 13 indexed citations
17.
Kuntal, Bhusan K., Polamarasetty Aparoy, & Pallu Reddanna. (2010). EasyModeller: A graphical interface to MODELLER. BMC Research Notes. 3(1). 226–226. 180 indexed citations
18.
Aparoy, Polamarasetty, et al.. (2009). Pharmacophore modeling and virtual screening for designing potential 5-Lipoxygenase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(3). 1013–1018. 16 indexed citations
19.
Aparoy, Polamarasetty, et al.. (2008). Homology modeling of 5-lipoxygenase and hints for better inhibitor design. Journal of Computer-Aided Molecular Design. 22(9). 611–619. 35 indexed citations
20.
Aparoy, Polamarasetty, et al.. (2007). Computer Aided Drug Design Approaches to Develop Cyclooxygenase Based Novel Anti-Inflammatory and Anti-Cancer Drugs. Current Pharmaceutical Design. 13(34). 3505–3517. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theodora M. Steindl Breakdown of academic impact, for papers by Zongru Guo Breakdown of academic impact, for papers by Florian Kaiser Breakdown of academic impact, for papers by Katrin Stierand Breakdown of academic impact, for papers by Vivek K. Vyas Breakdown of academic impact, for papers by Jonathan M. Schmidt Breakdown of academic impact, for papers by Song Wu Breakdown of academic impact, for papers by Vânia M. Moreira Breakdown of academic impact, for papers by Zhenquan Hu Breakdown of academic impact, for papers by Marco A. C. Neves
Rankless by CCL
2026